Sharing Life Sciences Innovations
Biotechs and subsidies - a fraught relationship
The ambition of any CEO heading a biotech start-up is to develop a new product and to reach patients quickly. However, drug development comes with long development timelines, making Biotech a capi…
Uncovering the secrets of inflammasomes
Mohamed (Mo) Lamkanfi made the jump from academia to industry a mere eight months ago, to pursue a career with the Janssen Pharmaceutical Companies of Johnson & Johnson, as Head, Innate Immunity, …
The world's smallest diamonds
Researchers at Hasselt University have just synthesised the world’s smallest diamonds. The gems, based on a 26-atom carbon core, will be useful in a whole range of industrial and medical applicati…
New beta cell antigens discovered in Type 1 diabetes
A study published just last week has unveiled several new antigens implicated in Type 1 diabetes. In an ongoing project, researchers are working to understand the immune system failures that cause…
Galapagos and MorphoSys to receive up to EUR 850mil in deal with Novartis
Galapagos (Belgium) and MorphoSys (Germany) recently announced that they have entered into an exclusive global license agreement with Novartis. The Swiss big-pharma partner has acquired the rights…
Cycling for Science
Researchers from Ghent University have been able to map the effects of climate change thanks to images of the Tour of Flanders. By studying 36 years of footage of the popular cycling race, the res…
1 billion lifeforms recorded!
The Global Biodiversity Information Facility (GBIF) is an international network that provides access to a huge biodiversity database. Their total number of occurrence records just reached 1 billio…
Acquisitions of Biotech companies: a good or a bad thing?
When on the 8th January 2018 the news travelled that Novo Nordisk made a €2.6bn bid for Belgium’s Ablynx, only to be leapfrogged a few weeks later by the € 3.9bn Sanofi bid, we immediately picture…
How to build a “European Amgen”
There are still very few large European biotech companies to compete with the Amgens and Gileads of the world. Only a handful of European biotech companies have managed to stay independent, grow,…
Confo Therapeutics is awarded a EUR 1M grant to increase its screening capabilities
Confo Therapeutics announced today that it has received a €1 million grant from the Flemish Government through Flanders Innovation & Entrepreneurship (VLAIO). The grant will be used to support the…
Sanofi acquires Ablynx for €3.9 billion
Sanofi and Ablynx entered into a definitive agreement under which Sanofi will offer to acquire all of the outstanding ordinary shares, including shares represented by American Depositary Shares (A…
Nominations open for Dr. Paul Janssen Award
Have you ever heard from the Dr. Paul Janssen award? It's an acknowledgement for biomedical research almost as important as a Nobel Prize. A trophy sculpture, along with $200,000 cash, will go to …
Join our 20.000 subscribers and receive the monthly newsletter for free!
Upcoming events
Dr. Paul Janssen Award for Biomedical Research
JANSSEN PHARMACEUTICA
Company Restaurant
Turnhoutseweg 30
2340 Beerse
Belgium
Thu 06 Sep 2018
14:30
Johnson & Johnson has named James Allison, Ph.D., of University of Texas MD Anderson Cancer Center, winner of the 2018 Dr. Paul Janssen Award for Biomedical Research. Dr. Allison won for pioneerin…
Structural Dynamics in Cellular Communication (2nd edition)
Brussels, Belgium
Thu 20 Sep 2018 - Fri 21 Sep 2018
20 Sep 09:00
- 21 Sep 17:00
After a successful first edition in January 2015, with a great audience and speakers such as Nobel Prize winner Ada Yonath, we are honored to announce a second edition. This conference wi…
Business Developers Program for Life Sciences - Course
Amsterdam, The Netherlands
Tue 25 Sep 2018 - Wed 26 Sep 2018
25 Sep 08:30
- 26 Sep 17:30
On 25 & 26 September 2018 the Business Developers Program (BDP) Course will take place at the EY office in Amsterdam. This BDP Course specifically aims at junior to mid-level BD professionals who …
